JERUSALEM, June 10, 2013 /PRNewswire/ --
Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP), a clinical-stage developer of oral delivery systems, announced today that it has been invited to present at the 12th National Life Science & Technology Week IATI-BioMed Conference taking place from June 10-12, 2013, in Tel Aviv, Israel. Josh Hexter, Oramed's Chief Operating Officer and Vice President of Business Development, will present on Tuesday, June 11th at 3:10 PM.
IATI-BioMed 2013 follows the success of previous annual conferences where the Israeli Life Science Industry (ILSI) hosted 6,000 industry players, engineers and scientists with approximately 1,000 participants from over 40 countries, and in excess of 3,500 one-on-one meetings.
The IATI-BioMed conference, formerly known as the ILSI-BioMed Conference, is Israel's premier life science conference showcasing the country's most advanced companies and technologies. Building on the great reputation established in previous years, IATI-BioMed offers attendees and presenters a winning mix of industry keynote speakers, exciting and innovative company presentations, and three days of exhibition and networking opportunities. In addition, the Academic Institution's Technology Transfer offices and scientists from Israel's universities and healthcare institutions are present throughout the event.
For more information on the IATI-BioMed conference, the content of which is not part of this press release, please visit: http://www2.kenes.com/biomed/Pages/Home.aspx
Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines currently delivered via injection. Established in 2006, Oramed'
|SOURCE Oramed Pharmaceuticals Inc.|
Copyright©2012 PR Newswire.
All rights reserved